Blood biomarkers such as procalcitonin (PCT), C‐reactive protein (CRP), Interleukin‐6 (IL‐6), white blood cell count and lactate6, 7 are commonly used to differentiate between patients with pneumonia and individuals with pneumonia at risk for sepsis. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.